Tays Cancer Centre Seminar series will start on Thursday 5.9. at 14.00.

Venua: Arvo-building, Kauppi-campus, Tampere University, lecture room: F114.

 

The first speaker is Academy Research Fellow, Daniela Ungureanu from Tampere University.
The title of her talk is:

MOLECULAR MECHANISM OF CHEMORESISTANCE IN OVARIAN CANCER

 

Daniela’s group is focusing on the role of Wnt-receptor pseudokinases (RORs, PTK7) in cancer development and chemoresistance. These pseudokinases contribute to the pathologies of several human diseases, most notably cancer, yet they remain largely unexplored as drug targets due to challenges associated with regulation of their biological functions. They are studying the functional mechanisms associated with ROR1/ROR2 expression alteration and tumorigenesis in hematological cancers and ovarian cancer. They are also interested in proteomics and HTP drug testing for functional studies of ex vivo patient samples. Their research is strongly supported by the close collaboration with clinicians at TAYS for patient samples collections and clinical studies, such in the case ovarian cancer.

Selected publications:
Karvonen H, Perttilä R, Niininen W, Hautanen V, Barker H, Murumägi A, Heckman CA, Ungureanu D. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. Oncogene. Jan 10. doi: 10.1038/s41388-018-0670-9,  2019

Karvonen H, Barker H, Kaleva L, Niininen W, Ungureanu D. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways. Cells. 2019 Aug 2;8(8). pii: E812. doi: 10.3390/cells8080812.

Veskimäe K, Scaravilli M, Niininen W, Karvonen H, Jaatinen S, Nykter M, Visakorpi T, Mäenpää J, Ungureanu D, Staff S. Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies. Translational Oncology. 11(5):1160-1170, 2018

Karvonen H, Chiron D, Niininen W, Ek S, Jerkeman M, Moradi E, Nykter M, Heckman CA, Kallioniemi O, Murumägi A, Ungureanu D. Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma. Blood Adv. 1(24):2257-2268, 2017

The Tays Cancer Centre seminar is organized in collaboration with the Faculty of Medicine and Health Technology, Tampere University.

Coffee and snacks before the seminar

All welcome!